T-Cell Therapy Market Size to Hit $21+ Billion with Booming CAGR Value of 20.7% by 2028 | The Insight Partners

Global T-cell therapy market growth is driven by increase in the number of cancer cases, especially lymphoma and leukaemia cases; rise in the investments in adoptive T-cell transfer approaches of disease treatment; and an increase in relapsed or refractory cancer cases showing negative response to alternate treatments, such as chemotherapy and radiation therapy.


New York, Oct. 20, 2022 (GLOBE NEWSWIRE) -- According to The Insight Partners latest study on "T-cell Therapy Market Size, Share, Trends, Growth Strategy and Forecast to 2028 – COVID-19 Impact and Global Analysis – by Modality, Therapy Type, Indication, and Geography," the global T-cell therapy market size is expected to grow from USD 5.66 billion in 2021 to USD 21.13 billion by 2028; it is expected to grow at a CAGR of 20.7% from 2022 to 2028.

Download Sample PDF Brochure of T-Cell Therapy Market Size - COVID-19 Impact and Global Analysis with Strategic Insights at: https://www.theinsightpartners.com/sample/TIPRE00024331/

Global T-Cell Therapy Market Report Scope, Segmentations, Regional & Country Scope:

Report CoverageDetails
Market Size Value inUSD 5.66 billion in 2021
Market Size Value byUSD 21.13 billion by 2028
Growth rateCAGR of 20.7% from 2022 to 2028
Forecast Period2022-2028
Base Year2021
No. of Pages150
Historical data availableYes
Segments coveredModality, Therapy Type, and Indication
Regional scopeNorth America; Europe; Asia Pacific; Latin America; MEA
Country scopeUS, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina
Report coverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends

Global T-Cell Therapy Market: Competitive Landscape

Novartis AG, Pfizer Inc., Merck KGaA, Bluebird Bio Inc., Celgene Corporation, Gilead Sciences Inc., Amgen Adaptimmune, Sorrento Therapeutics, and TCR2 Therapeutics Inc. are a few of the key players profiled during the study of the T-cell therapy market. Several other major companies were analyzed during this study to get a holistic view of the market and its ecosystem.

North America dominated the global T-cell therapy market with ~41% market share in 2021. The market growth in the region is majorly attributed to the extensive research and a commercial base for cancer immunotherapy, combined with a large number of clinical trials for T-cell therapies in the US. Furthermore, the increasing number of regulatory approvals for T-cell therapies in the US and Canada, as well as the region's changing reimbursement scenario, has driven the market growth. The presence of a significant number of medical facilities offering CAR-T cell therapies also contributes to the regional market growth.

Inquiry Before Purchase: https://www.theinsightpartners.com/inquiry/TIPRE00024331/

Increase in product approval and technological advancements in T-cell manufacturing capabilities support Global T-cell therapy market:

Rising number of product approvals and improving manufacturing capabilities would drive the T-cell therapy market growth in the coming years. Following the approval of Yescarta, Kymriah, and Tecartus, many companies have switched from developing protein- and small-molecule-based treatments to adoptive therapies. The market for T-cell therapy has grown due to strategic initiatives made in this area by public and private organizations. As per research study published  by American Journal of Transplantationi n 2020, T-cell therapy can be used in the treatment of high-risk COVID-19 patients. Also, in September 2020, the US FDA approved the IND application for ALVR109 to treat COVID-19 patients. Additionally, due to the global COVID-19 pandemic, the rising use of T-cell therapy in the treatments for viral infections is surging the funding for T-cell therapies. 

With increased investments in the gene therapy industry, the T-cell therapy market is expected to grow steadily during the forecast period. Companies, such as Novartis AG, are actively investigating the potential of CAR-T-based gene therapies for various chronic diseases. Moreover, T-cell-based mechanisms are widely used in cancer immunotherapy as more than 350 CAR-T clinical trials had been registered in China as of June 2020. Furthermore, the vast majority of operating players are investing in CD19 CAR-T therapies to strengthen their market positions.

Impact of COVID-19 Pandemic on Global T-Cell Therapy Market:

COVID-19 pandemic opportunities for market players to invest in T-cell therapies research for viral infection. The scientific community is actively engaged in finding the potential use of T-cell therapy to treat high-risk COVID-19 patients, resulting in increased adoption of T-cell therapeutics. Moreover, due to disruptions across the supply chain, several market players are preferring digital alternatives to manage the cell therapy supply chain, which is anticipated to bolster the market growth. Hence, the market experienced positive impact of the pandemic.

Quickly Purchase Premium Copy of T-Cell Therapy Market Growth Report (2022-2028) at: https://www.theinsightpartners.com/buy/TIPRE00024331/

e-Insights: e-Insights is the one stop solution for all your market research needs. It includes market size and forecast of millions of market nodes along with thousands of company profiles and live news feed.


The e-Insights includes repository of over thousands of reports spread across important domains such as Aerospace & Defence; Automotive & Transportation; Biotechnology; Chemicals & Materials; Electronics & Semiconductor; Energy & Power; Food & Beverages; Healthcare IT; Manufacturing & Construction; Medical Device; Pharmaceuticals; Technology, Media, & Telecommunications.


Each report provides in-depth analysis on the topic and discusses drivers, restraints, and opportunities available in the market. The e-Insights is designed to help our clients in their decision support system. The analysis also covers the complete spectrum of the research topic to assist our clients in meeting their business objectives.


Company section in the report covers the global players (existing and emerging). We bone up all the companies listed in the report post our desk research based on parameters such as company revenue, product portfolio, and geographic presence.


News sections track the latest developments from the subscribed sectors and keep you informed with the most updated information on competition and regulations.

Request for Demo: https://www.theinsightpartners.com/e-Insights/

Browse Related Reports:

Cell-Based Immunotherapy Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Therapy (Autologous Cellular Immunotherapy, Chimeric Antigen Receptor (CAR) T-Cell Therapy, Dendritic Cell-based Vaccine Therapy); Indication (B-cell Malignancies, Prostate Cancer, Renal Cell Carcinoma, Liver Cancer, Others)

Proton Therapy System Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Application (Head and Neck Cancer, Brain Cancer, Sarcoma, Pediatric Cancer, Gastro-Intestinal Cancer, Prostate Cancer, Lung Cancer); End User (Hospital, Clinics, Ambulatory Surgery Center, Others) and Geography

Cancer mTOR Inhibitors Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Torisel, Afinitor, Afinitor Dizperz, Others); Application (Cancer, Neuroendocrine Tumors, Hematological Malignancy, Hepatocellular Carcinoma, Glioblastoma) and Geography

Peptide Cancer Vaccine Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Cancer Type (Breast Cancer, Lung Cancer, Melanoma, Prostate Cancer, Others); Vaccine Type (Personalized Peptide Vaccine, Peptide-Pulsed Dendritic Cancer Vaccine, Peptide Cocktail Type, Multivalent Peptide Vaccine, Others) and Geography

Chimeric Antigen Receptor (CAR)-T Therapy Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Therapeutic Application (Leukemia, Pancreatic Cancer, Breast Cancer, Lung Cancer, Gastric Cancer, Others); Structure (First Generation CAR-T Cells, Second Generation CAR-T Cells, Third Generation CAR-T Cells, Others); Development Processes (Autologous CAR-T Cells, Allogeneic CAR-T Cells, Others); End User (Hospitals, Homecare, Specialty Clinics, Others) and Geography

Gene Therapy Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Vector ( Non-Viral Vectors, Viral Vectors ); Indication ( Neurological Diseases, Cancer, Duchenne Muscular Dystrophy, Hepatological Diseases, Other Indications (Retinal Diseases, Beta-Thalassemia) ); Delivery Mode ( In-Vivo, Ex-Vivo )

Cold Plasma Market Forecast to 2028 -  Covid-19 Impact and Global Analysis - By Application (Wound Healing, Blood Coagulation, Cancer Treatment, Dentistry, and Others), Regime (Low-Pressure Cold Plasma and Atmospheric Cold Plasma) and Geography

Pancreatic Cancer Therapy Market to 2025 - Global Analysis and Forecasts By Type (Endocrine Pancreatic Cancer and Exocrine Pancreatic Cancer), Therapy (Biology, Chemotherapy and Others) and Geography

Liver Diseases Treatment Market to 2025 - Global Analysis and Forecasts by Diseases (Cirrhosis, Hepatitis, Cancer and Other Diseases), Imaging Modality (Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Ultrasound, and Other Modalities) and Geography

Gene Panel Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product and Service (Testing Services, Test Kits); Technique (Hybridization-Based Approach, Amplicon-Based Approach); Application (Cancer Risk Assessment, Diagnosis of Congenital Disorders, Pharmacogenetics, Other Applications); Design (Customized Gene Panels, Predesigned Gene Panels); End User (Hospitals and Diagnostic Laboratories, Research and Academic Institutes, Pharmaceutical and Biotechnology Companies)

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:
If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
Press Release: https://www.theinsightpartners.com/pr/t-cell-therapy-market